{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T08:54:59Z","timestamp":1773305699600,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.amjcard.2020.05.018","type":"journal-article","created":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T02:26:07Z","timestamp":1589768767000},"page":"71-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Nonusefulness of Antithrombotic Therapy After Surgical Bioprosthetic Aortic Valve Replacement"],"prefix":"10.1016","volume":"129","author":[{"given":"Anton A.","family":"Gryaznov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayman","family":"Saeyeldin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad","family":"Abdelbaky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1666-199X","authenticated-orcid":false,"given":"Mohammad A.","family":"Zafar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Tanweer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitra","family":"Papanikolaou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahnoor","family":"Imran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yupeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5190-4654","authenticated-orcid":false,"given":"Bulat A.","family":"Ziganshin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Elefteriades","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2020.05.018_bib0001","article-title":"Epidemiology of valvular heart disease in the adult","volume":"8","author":"Lung","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.amjcard.2020.05.018_bib0002","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(09)60780-7","article-title":"Antithrombotic management of patients with prosthetic heart valves: current evidence and future trends","volume":"374","author":"Sun","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2020.05.018_bib0003","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/heartjnl-2014-307020","article-title":"The modern epidemiology of heart valve disease","volume":"102","author":"Coffey","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.amjcard.2020.05.018_bib0004","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1016\/j.jacc.2009.10.085","article-title":"Choice of prosthetic heart valve in adults an update","volume":"55","author":"Rahimtoola","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2020.05.018_bib0005","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jacc.2017.03.011","article-title":"2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"70","author":"Nishimura","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2020.05.018_bib0006","first-page":"110","article-title":"2017 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"71","author":"Baumgartner","year":"2018","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"10.1016\/j.amjcard.2020.05.018_bib0007","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","article-title":"2017 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"38","author":"Baumgartner","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2020.05.018_bib0008","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000490924","article-title":"Antithrombotic therapy after bioprosthetic aortic valve replacement: a therapeutic morass","volume":"140","author":"Gryaznov","year":"2018","journal-title":"Cardiology"},{"key":"10.1016\/j.amjcard.2020.05.018_bib0009","first-page":"II214","article-title":"Comparison of anticoagulation regimens after Carpentier-Edwards aortic or mitral valve replacement","volume":"90","author":"Blair","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2020.05.018_bib0010","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/0735-1097(94)00563-6","article-title":"High risk of thromboemboli early after bioprosthetic cardiac valve replacement","volume":"25","author":"Heras","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2020.05.018_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2012.05.029","article-title":"Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database","volume":"60","author":"Brennan","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2020.05.018_bib0012","first-page":"610","article-title":"Prevention of thromboembolism with ticlopidine shortly after valve repair or replacement with a bioprosthesis","volume":"7","author":"Aramendi","year":"1998","journal-title":"J Heart Valve Dis"},{"key":"10.1016\/j.amjcard.2020.05.018_bib0013","first-page":"78","article-title":"Patterns of anticoagulation following bioprosthetic valve implantation: observations from ANSWER","volume":"21","author":"Brennan","year":"2012","journal-title":"J Heart Valve Dis"},{"key":"10.1016\/j.amjcard.2020.05.018_bib0014","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1161\/01.CIR.0000137122.95108.52","article-title":"Comparing warfarin with aspirin after biological aortic valve replacement: a prospective study","volume":"110","author":"Gherli","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2020.05.018_bib0015","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.ejcts.2004.12.064","article-title":"Triflusal versus oral anticoagulation for primary prevention of thromboembolism after bioprosthetic valve replacement (trac): prospective, randomized, co-operative trial","volume":"27","author":"Aramendi","year":"2005","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.amjcard.2020.05.018_bib0016","first-page":"II95","article-title":"Anticoagulation is unnecessary after biological aortic valve replacement","volume":"98","author":"Moinuddeen","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2020.05.018_bib0017","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.thromres.2016.11.021","article-title":"Antithrombotic therapy after bioprosthetic aortic valve implantation: Warfarin versus aspirin, a randomized controlled trial","volume":"150","author":"Rafiq","year":"2017","journal-title":"Thromb Res"},{"key":"10.1016\/j.amjcard.2020.05.018_bib0018","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jtcvs.2004.11.028","article-title":"Is early anticoagulation with warfarin necessary after bioprosthetic aortic valve replacement?","volume":"129","author":"Sundt","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.amjcard.2020.05.018_bib0019","series-title":"R: A Language and Environment for Statistical Computing","year":"2017"},{"key":"10.1016\/j.amjcard.2020.05.018_bib0020","first-page":"667","article-title":"Comparing warfarin to aspirin (WoA) after aortic valve replacement with the St. Jude medical epic heart valve bioprosthesis: results of the WoA epic pilot trial","volume":"16","author":"Colli","year":"2007","journal-title":"J Heart Valve Dis"},{"key":"10.1016\/j.amjcard.2020.05.018_bib0021","doi-asserted-by":"crossref","first-page":"128","DOI":"10.5761\/atcs.oa.16-00297","article-title":"Early antithrombotic therapy after bioprosthetic aortic valve replacement in elderly patients: a single-center experience","volume":"23","author":"Lee","year":"2017","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"10.1016\/j.amjcard.2020.05.018_bib0022","first-page":"574","article-title":"Experience with low-dose aspirin as thromboprophylaxis for the Tissuemed porcine aortic bioprosthesis: a survey of five years' experience","volume":"7","author":"Goldsmith","year":"1998","journal-title":"J Heart Valve Dis"},{"key":"10.1016\/j.amjcard.2020.05.018_bib0023","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1161\/CIRCOUTCOMES.115.002696","article-title":"Safety and use of anticoagulation after aortic valve replacement with bioprostheses: a meta-analysis","volume":"9","author":"Riaz","year":"2016","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.amjcard.2020.05.018_bib0024","first-page":"349","article-title":"Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group","volume":"2","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2020.05.018_bib0025","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/0735-1097(95)00044-5","article-title":"Referral for coronary artery revascularization procedures after diagnostic coronary angiography: evidence for gender bias?","volume":"25","author":"Bell","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2020.05.018_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2007.08.024","article-title":"European guidelines on cardiovascular disease prevention in clinical practice: executive summary","volume":"194","author":"Graham","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.amjcard.2020.05.018_bib0027","doi-asserted-by":"crossref","first-page":"396","DOI":"10.7326\/0003-4819-150-6-200903170-00008","article-title":"Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement","volume":"150","year":"2009","journal-title":"Ann Intern Med"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000291492030494X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000291492030494X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:35:02Z","timestamp":1757572502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000291492030494X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":27,"alternative-id":["S000291492030494X"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2020.05.018","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.738260471.793577732","asserted-by":"object"}]},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonusefulness of Antithrombotic Therapy After Surgical Bioprosthetic Aortic Valve Replacement","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2020.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}